Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pia Frisk"'
Introduction and utilisation of high priced HCV medicines across Europe; implications for the future
Autor:
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana Sović Brkičić, Anna Bucsics, Guillame Dedet, Jaran Eriksen, Joseph O Fadare, Jurij Fürst, Gisselle Gallego, Isabella Piassi Godói, Augusto Afonso Guerra Junior, Hakki Gürsöz, Saira Jan, Jan Jones, Saim Kerman, Roberta Joppi, Ott Laius, Newman Madzikwa, Einar Magnusson, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O’Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalene Wladysiuk, Sortiris Vandoros, Elif Hilal Vural, Corinne Zara, Brian Godman
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Background: Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a diagnosed prevalence of 2.0%. Fortunately, it is now curable in most patients. Sales of medicines to treat HCV infection grew 2.7% per year between 20
Externí odkaz:
https://doaj.org/article/442ad35f14564b47bc0809c09511b491
Publikováno v:
The International journal of pharmacy practice. 27(4)
Background Creating evidence of effectiveness is an important part of service development. In an ongoing research project Swedish community pharmacists participate in services research by recruiting patients initiated on statins to an adherence-promo
Autor:
Björn Wettermark, O. Weiland, Pia Frisk, Thomas Cars, K. Aggefors, Nils Feltelius, S. A. Loov
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Introduction of the direct-acting antivirals (DAAs) for treatment of chronic hepatitis C (CHC) infection has been challenging in all health systems. In Sweden, a national protocol for managed introduction was developed. It was optional, but a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f58bf7f6770f070762436249412f064
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358273
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358273
Publikováno v:
International Journal of Clinical Pharmacy. 37:522-528
Background Patient self-reported data are important in drug utilization research, but often logistically difficult to collect. During 2006–2012, 72 Swedish community pharmacies regularly collected such data through structured survey interviews at t
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:128-139
PurposeTo evaluate if there is a selection bias in drug utilization surveys on prescription drugs regularly conducted in Swedish pharmacies, to describe the direction of this potential bias and dis ...
Publikováno v:
European journal of clinical pharmacology. 72(6)
Triptans are widely used in acute migraine, and in some countries, they are also available over-the-counter (OTC). In Sweden, sales have increased for both prescription and OTC triptans. This study aimed to describe current prescribing and utilisatio
Publikováno v:
Journal of Pharmaceutical Health Services Research. 2:9-15
Objectives Generic substitution for reimbursed drugs was introduced in Sweden on 1 October 2002. This study aimed to evaluate how Swedish drug consumers experience generic substitution, 5 years after implementation. Methods Pharmacy customers over 18
Publikováno v:
Lakartidningen. 109(20-21)
Autor:
Björn Wettermark, Tor-Olov Mellgren, Pia Frisk, Anita Berlin, Niklas Hedberg, Fredrik Granath
Publikováno v:
European journal of clinical pharmacology. 64(12)
Angiotensin receptor blockers (ARBs) offer a new treatment alternative for patients with hypertension and heart failure. Due to comparatively high prices, most guidelines suggest ARBs be restricted to patients intolerant to angiotensin-converting enz